Skip to main content
Clinical Trials/NCT01915641
NCT01915641CompletedNot Applicable

CPAP Improves the Walking Capacity in Patients With COPD and OSA

Chang Gung Memorial Hospital1 site in 1 country60 target enrollmentStarted: April 1, 2013Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
60
Locations
1
Primary Endpoint
exercise capacity (walking distance (meter), measured by incremental shuttle walking test)

Study Overview

Brief Summary

We have reported that CPAP treatment improved the walking capacity of overlap syndrome patients.

However, the previous study was not randomized, double blinded study. Therefore, we design a prospective, randomized, double blinded, controlled, cross-over trial to confirm this finding.

Detailed Description

inclusion criteria :

  • COPD : FEV1/FVC < 70%, no response to bronchodilator (FEV1 change <12% and <200ml)
  • OSA : AHI > 15/h, obstructive type predominant

exclusion criteria :

  • any malignancy
  • pregnancy
  • claustrophobia
  • age<18

primary outcome : exercise capacity (walking distance (meter), measured by incremental shuttle walking test)

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Treatment
Masking
Triple (Participant, Care Provider, Investigator)

Eligibility Criteria

Ages
18 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • FEV1/FVC < 70%, no response to bronchodilator (FEV1 change <12% and <200ml)
  • OSA : AHI > 15/h, obstructive type predominant

Exclusion Criteria

  • any malignancy
  • pregnancy
  • claustrophobia

Outcomes

Primary Outcomes

exercise capacity (walking distance (meter), measured by incremental shuttle walking test)

Time Frame: CPAP treatment for 1 month

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Chang Gung Memorial Hospital
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials